NPR’s Mary Louise Kelly talks with Rick Bright, former Biomedical Advanced Research and Development Authority director, about his whistleblower complaint on political pressure over the coronavirus.
NPR’s Audie Cornish talks with William Foege, former director of the Centers for Disease Control and Prevention, about his letter on how to restore faith in the agency despite political interference.
President Trump continues to tout an experimental treatment he received for COVID-19. NPR discusses if the drug is safe and whether there is enough of it to distribute across the U.S.
“Republicans have been trying to drive a stake into the heart of Obamacare pretty much since it was passed — both through legislation and litigation,” New York Times reporter Sarah Kliff says.
Since the coronavirus can spread through the air, scientists say plexiglass barriers alone may not be enough protection. But a contraption using duct tape, HEPA filters and box fans could help a lot.
New enforcement guidelines are now in place, pushing hospitals to comply with rigorous reporting requirements, or risk losing a crucial funding stream from the federal government.
One in four rural households report being unable to get medical care for serious problems, due to the pandemic, according to a new poll from NPR, the Robert Wood Johnson Foundation and Harvard.
President Trump will continue to get top-of-the-line medical care for COVID-19 now that he’s back at the White House, including the final dose of the new antiviral medication, remdesivir
Few medical residents learn about the health effects of climate change. Now as wildfires sweep the West and hurricanes flood the Gulf Coast, the first published guidelines offer a way to start.